Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Granules India Limited
Press Release Feb 24 2021
Published Feb 24 2021
4 min read

Press Release Feb 24 2021

Granules India Limited has informed the Exchange regarding a press release dated February 24, 2021, titled "Granules India Limited announces approval of Acetaminophen, Aspirin and Caffeine Tablets (OTC), generic equivalent of Excedrin Migraine Tablets of GlaxoSmithKline Consumer Healthcare".

View Attachment